26 news items
Lilly announces departure of Anat Ashkenazi, chief financial officer
LLY
5 Jun 24
, uncertainties and risks related to engaging in business globally; unexpected safety or efficacy concerns associated with the company's products; litigation
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting
LLY
1 Jun 24
(23%), nausea (11%), and fatigue (10%). The safety profile for patients who discontinued a prior KRAS G12C inhibitor due to toxicity was similar
Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
LLY
NVO
29 May 24
versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly due to safety concerns.
Image Via Pixabay
Elon Musk Says Ozempic 'Will Become Very Cheap' After New Comedy Special Paints It As Weight Loss Drug Only Wealthy People Can Afford
LLY
NVO
PARA
25 May 24
banned replica versions of popular weight-loss drugs, including Ozempic and Mounjaro, due to safety concerns
Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
LLY
24 May 24
, support pipeline growth and leverage the latest technology and automation for maximum efficiency, safety and quality control. Importantly, we
d6x3mk707r828rvaq22n6qyobsj4r
LLY
24 May 24
pipeline growth and leverage the latest technology and automation for maximum efficiency, safety and quality control. Importantly, we are investing
h03jqyqg fw
LLY
23 May 24
)In a rapid oral abstract presentation, Lilly will report results from the Phase 1/2 LIBRETTO-121 study evaluating the safety
7y72pzzcejazq8vk6yf
LLY
NVO
22 May 24
And Co’s (NYSE:LLY) Mounjaro, citing safety concerns.
Recently
9a74tnl5mms3y1wjop1hpziopw6uxgis98gsuj76h6i8yu8wex457cs
BHVN
GPCR
LLY
21 May 24
safety concerns, setting it apart from other oral weight-loss drug candidates.
“We think GPCR’s market share in the oral market can
0si7rb4cm0ij6k2llpxvgkvb4akdpom8dyvw27zk
LLY
21 May 24
safety profile of mirikizumab in patients with moderately to severely active Crohn's disease was consistent with the known safety profile
z56fzkncm8a9ifcnkic4gmd5frhujvxl
LLY
16 May 24
compared to the most commonly used daily basal insulins globally.
QWINT-2 evaluated the efficacy and safety of once-weekly efsitora compared
9id4a8568m936crptuc194f70t7cis
LLY
16 May 24
evaluated the efficacy and safety of once-weekly efsitora compared to once-daily insulin degludec for 52 weeks. The trial randomized insulin-naïve adults
z3z3xqxv4 cxgnne9un8r
LLY
7 May 24
, is a double-blind, placebo-controlled study to evaluate the safety and efficacy of donanemab in participants ages 60-85 years with early symptomatic
aqfn7wmrg48v89w
LLY
30 Apr 24
, which evaluated the efficacy and safety of donanemab in early symptomatic Alzheimer's disease
yk1945oijvc01 f53bdzq45gr4o2ljxpaiujq459qe05
LLY
22 Apr 24
dedicated to Lilly's manufacturing mission to deliver medicines to patients with safety first and quality always.Weil, Gotshal & Manges LLP
qthau hacxc
LLY
17 Apr 24
.
The overall safety profile of tirzepatide in SURMOUNT-OSA studies was similar to previously reported SURMOUNT
40rlrnxni372zmgq0nyce7eb0wzogw
LLY
NVO
12 Apr 24
instances, raising concerns about the safety and efficacy
y8quetjkix6nzvacb0zf7s8yhq xxfspjffwryx755kwg8w6y92aagtco
AZN
LLY
NVO
12 Apr 24
will continue monitoring these events and updating their safety reports accordingly.
Additionally, the PRAC approved a communication plan
863bkddne53tg82s27bo2u8y43rviw6qhl 7bhwgek61y
LLY
NVO
12 Apr 24
new evidence on this issue in their Periodic Safety Update Reports (PSURs).
vwccq1 1wvx1l8h65q9qfis9btb
BEAM
LLY
VERV
2 Apr 24
independent data and safety monitoring board (DSMB), Verve has decided to pause enrollment in the Heart-1 clinical trial.
Verve